![]() |
|
|
Vol. 281, Issue 3, 1257-1263, 1997
Institute for Cardiovascular Research, Leeds University, Leeds LS2
9JT, U.K.
The ability of angiotensin II (AII) to regulate
[Ca++]i in human neuroblastoma (SH-SY5Y)
cells stably expressing recombinant rat AT1A receptors was
investigated using microfluorimetric methods, and compared to responses
obtained by stimulation of native muscarinic receptors. Applications of
AII or carbachol produced biphasic rises of
[Ca++]i, but in Ca++-free
solutions (containing 1 mM ethylene glycol-bis (
-aminoethyl ether)N,N,N,'N'-tetraacetic acid), both agonists produced only transient monophasic rises of [Ca++]i, and
second applications were without effect. Application of Ca++o (2.5 mM) to cells after exposure to
either agonist produced a Ni2+-sensitive rise of
[Ca++]i in the absence of agonist
("capacitative Ca++ influx"). After removal of
Ca++o, both AII and carbachol elicited a second
rise of [Ca++]i. Thapsigargin (1 µM)
prevented these second rises of [Ca++]i.
During capacitative Ca++ influx, application of AII failed
to produce a further rise of [Ca++]i. In
contrast, carbachol produced a further rise of
[Ca++]i, attributable to activation of both
nicotinic and muscarinic receptors, because it was reduced (but not
abolished) by mecamylamine (1 µM) and was observed when muscarine was
used as the agonist. Thus, activation of recombinant AT1A
and muscarinic receptors in SH-SY5Y cells leads to mobilization of
Ca++ from a common intracellular pool, and stimulates
capacitative Ca++ influx. Muscarinic (but not AII) receptor
occupancy is capable of stimulating an additional Ca++
influx pathway.